Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Cover TL, Blanke SR (2005) Nat Rev Microbiol 3: 320-32 Helicobacter pylori and gastroduodenal disease. Cover TL, Blaser MJ (1992) Annu Rev Med 43: 135-45 Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Griffin MR, Ray WA, Schaffner W (1988) Ann Intern Med 109: 359-63 Nonsteroidal anti-inflammatory drug use and increased risk for peptic ulcer disease in elderly persons. Griffin MR, Piper JM, Daugherty JR, Snowden M, Ray WA (1991) Ann Intern Med 114: 257-63 Corticosteroid use and peptic ulcer disease: role of nonsteroidal anti-inflammatory drugs. Piper JM, Ray WA, Daugherty JR, Griffin MR (1991) Ann Intern Med 114: 735-40 Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs. Ray WA, Chung CP, Stein CM, Smalley WE, Hall K, Arbogast PG, Griffin MR (2007) Gastroenterology 133: 790-8 Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells. Romano M, Ricci V, Di Popolo A, Sommi P, Del Vecchio Blanco C, Bruni CB, Ventura U, Cover TL, Blaser MJ, Coffey RJ, Zarrilli R (1998) J Clin Invest 101: 1604-13 Analysis of iceA genotypes in South African Helicobacter pylori strains and relationship to clinically significant disease. Kidd M, Peek RM, Lastovica AJ, Israel DA, Kummer AF, Louw JA (2001) Gut 49: 629-35 The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Pagliaccia C, de Bernard M, Lupetti P, Ji X, Burroni D, Cover TL, Papini E, Rappuoli R, Telford JL, Reyrat JM (1998) Proc Natl Acad Sci U S A 95: 10212-7 Studies of gastric ulcer disease by community-based gastroenterologists. Brazer SR, Tyor MP, Pancotto FS, Nickl NJ, Wildermann NM, Harrell FE, Pryor DB (1990) Am J Gastroenterol 85: 824-8 Underutilization of gastroprotective measures in patients receiving nonsteroidal antiinflammatory drugs. Smalley W, Stein CM, Arbogast PG, Eisen G, Ray WA, Griffin M (2002) Arthritis Rheum 46: 2195-200 Density of Helicobacter pylori infection in vivo as assessed by quantitative culture and histology. Atherton JC, Tham KT, Peek RM, Cover TL, Blaser MJ (1996) J Infect Dis 174: 552-6 No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease. Smalley WE, Ray WA, Daugherty JR, Griffin MR (1998) Am J Epidemiol 148: 350-4 Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. Atherton JC, Cao P, Peek RM, Tummuru MK, Blaser MJ, Cover TL (1995) J Biol Chem 270: 17771-7 Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Cover TL, Dooley CP, Blaser MJ (1990) Infect Immun 58: 603-10 Helicobacter pylori VacA induces programmed necrosis in gastric epithelial cells. Radin JN, González-Rivera C, Ivie SE, McClain MS, Cover TL (2011) Infect Immun 79: 2535-43 Decreased prevalence of Helicobacter pylori infection in gastroesophageal reflux disease. Varanasi RV, Fantry GT, Wilson KT (1998) Helicobacter 3: 188-94 The association of cigarette smoking with self-reported disease before middle age: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Hozawa A, Houston T, Steffes MW, Widome R, Williams OD, Iribarren C, Pletcher MJ, Daviglus ML, Carr JJ, Jacobs DR (2006) Prev Med 42: 193-9 Reserpine reconsidered: no association with serious peptic ulcer disease. Shorr RI, Ray WA, Daugherty JR, Griffin MR (1993) J Gen Intern Med 8: 510-2 Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee. McManus P, Primrose JG, Henry DA, Birkett DJ, Lindner J, Day RO (1996) Med J Aust 164: 589-92 Expression of the cell adhesion molecule CD44 in gastric adenocarcinomas. Washington K, Gottfried MR, Telen MJ (1994) Hum Pathol 25: 1043-9 Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease. Tham KT, Peek RM, Atherton JC, Cover TL, Perez-Perez GI, Shyr Y, Blaser MJ (2001) Hum Pathol 32: 264-73 Is there a place for non-selective NSAIDs in the treatment of arthritis? Crofford LJ (2002) Joint Bone Spine 69: 4-7 The role of CagA status in gastric and extragastric complications of Helicobacter pylori. Perez-Perez GI, Peek RM, Legath AJ, Heine PR, Graff LB (1999) J Physiol Pharmacol 50: 833-45 Helicobacter pylori vacuolating cytotoxin (VacA) disorganizes the cytoskeletal architecture of gastric epithelial cells. Pai R, Cover TL, Tarnawski AS (1999) Biochem Biophys Res Commun 262: 245-50 Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. Murthy R, Brown DB, Salem R, Meranze SG, Coldwell DM, Krishnan S, Nunez R, Habbu A, Liu D, Ross W, Cohen AM, Censullo M (2007) J Vasc Interv Radiol 18: 553-61; quiz 562
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.